BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 34792614)

  • 1. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should Pyloric Lymph Nodes Be Dissected for Siewert Type II and III Adenocarcinoma of the Esophagogastric Junctions: Experience from a High-Volume Center in China.
    Cao H; Ooi M; Yu Z; Wang Q; Li Z; Lu Q; Wu Y
    J Gastrointest Surg; 2019 Feb; 23(2):256-263. PubMed ID: 30334176
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should Splenic Hilar Lymph Nodes be Dissected for Siewert Type II and III Esophagogastric Junction Carcinoma Based on Tumor Diameter?: A Retrospective Database Analysis.
    Lv CB; Huang CM; Zheng CH; Li P; Xie JW; Wang JB; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Tu RH
    Medicine (Baltimore); 2016 May; 95(21):e3473. PubMed ID: 27227913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neoadjuvant chemoradiotherapy combined with surgery versus direct surgery in the treatment of Siewert type II and III adenocarcinomas of the esophagogastric junction: long-term prognostic analysis of a prospective randomized controlled trial].
    Tian Y; Wang Q; Wang J; Qiao XY; Zhang J; Lin YC; Li Y; Fan LQ; Yang PG; Zhao Q
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Feb; 24(2):128-137. PubMed ID: 33508918
    [No Abstract]   [Full Text] [Related]  

  • 9. Proximal Gastrectomy versus Total Gastrectomy for Siewert Type II Adenocarcinoma of the Esophagogastric Junction: A Comprehensive Analysis of Data from the SEER Registry.
    Zhu K; Xu Y; Fu J; Mohamud FA; Duan Z; Tan S; Zhao Z; Chen P; Zong L
    Dis Markers; 2019; 2019():9637972. PubMed ID: 31976023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic-assisted versus open total gastrectomy for Siewert type II and III esophagogastric junction carcinoma: a propensity score-matched case-control study.
    Huang CM; Lv CB; Lin JX; Chen QY; Zheng CH; Li P; Xie JW; Wang JB; Lu J; Cao LL; Lin M; Tu RH
    Surg Endosc; 2017 Sep; 31(9):3495-3503. PubMed ID: 27981384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel abdominal approach for dissection of advanced type II/III adenocarcinoma of the esophagogastric junction: a new surgical option.
    Hu C; Zhu HT; Xu ZY; Yu JF; Du YA; Huang L; Yu PF; Wang LJ; Cheng XD
    J Int Med Res; 2019 Jan; 47(1):398-410. PubMed ID: 30296865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prognostic significance of the number of dissected lymph nodes in Siewert type Ⅱadenocarcinoma of the esophagogastric junction without lymphatic metastasis].
    Wang JQ; Wei DZ; Xie MR; Xu SB; Ma DC
    Zhonghua Zhong Liu Za Zhi; 2016 Apr; 38(4):300-4. PubMed ID: 27087378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The optimal extent of lymph node dissection for adenocarcinoma of the esophagogastric junction differs between Siewert type II and Siewert type III patients.
    Goto H; Tokunaga M; Miki Y; Makuuchi R; Sugisawa N; Tanizawa Y; Bando E; Kawamura T; Niihara M; Tsubosa Y; Terashima M
    Gastric Cancer; 2014 Mar; 18(2):375-81. PubMed ID: 24658651
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transthoracic single-port-assisted laparoscopic gastrectomy versus laparoscopic transhiatal approach for Siewert type II adenocarcinoma of the esophagogastric junction: a single-center retrospective study.
    Li J; Xiong W; Ou H; Yang T; Jiang S; Huang H; Zheng Y; Luo L; Peng X; Wang W
    Surg Endosc; 2024 Apr; 38(4):1986-1994. PubMed ID: 38381159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal Extent of Lymph Node Dissection for Siewert Type II Esophagogastric Junction Adenocarcinoma.
    Peng J; Wang WP; Yuan Y; Hu Y; Wang Y; Chen LQ
    Ann Thorac Surg; 2015 Jul; 100(1):263-9. PubMed ID: 25980597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surgical and survival outcomes after laparoscopic and open gastrectomy for serosa-invasive Siewert type II/III esophagogastric junction carcinoma: a propensity score matching analysis.
    Lin X; Wan J; Li Z; Yan M; Liu J; Shi Y; Qian F; Zhao Y
    Surg Endosc; 2022 Jul; 36(7):5055-5066. PubMed ID: 34761283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of involved abdominal lymph nodes is correlated with the distance from the esophagogastric junction to the distal end of the tumor in Siewert type II tumors.
    Mine S; Kurokawa Y; Takeuchi H; Kishi K; Ito Y; Ohi M; Matsuda T; Hamakawa T; Hasegawa S; Yoshikawa T; Hiki N
    Eur J Surg Oncol; 2015 Oct; 41(10):1348-53. PubMed ID: 26087995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of the therapeutic efficacy of radical gastrectomy in Siewert type Ⅱ and Ⅲ adenocarcinoma of the esophagogastric junction].
    Zheng GL; Zheng ZC; Zhao Y; Zhang T; Zhang JJ
    Zhonghua Zhong Liu Za Zhi; 2016 Jul; 38(7):538-42. PubMed ID: 27531269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and feasibility of total laparoscopic radical resection of Siewert type II gastroesophageal junction adenocarcinoma through the left diaphragm and left thoracic auxiliary hole.
    Huang Y; Liu G; Wang X; Zhang Y; Zou G; Zhao Z; Cao Z; Zhao H; Yuan X; Zhang C
    World J Surg Oncol; 2021 Mar; 19(1):73. PubMed ID: 33714262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparison of the superiority of different TNM staging systems in Siewert III adenocarcinoma of esophagogastric junction].
    Lu Y; Xi H; Xie T; Qiu Z; Wang X; Wei B; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):143-148. PubMed ID: 30799536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.